Human-cl rhFVIII

BIOLOGICAL4 trials

Sponsors

Octapharma

Conditions

Hemophilia ASevere Haemophilia ASevere Hemophilia A

Phase 2

Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A

CompletedNCT00989196

OctapharmaHemophilia A

Start: 2010-05-31End: 2012-09-30Updated: 2019-10-08

Phase 3

Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs)

CompletedNCT01341912

OctapharmaSevere Hemophilia A

Start: 2011-06-30End: 2012-08-31Updated: 2020-03-17

Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A

CompletedNCT01863758

OctapharmaSevere Haemophilia A

Start: 2013-08-31End: 2015-01-31Updated: 2018-01-30

Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII

CompletedNCT01992549

OctapharmaSevere Hemophilia A

Start: 2014-04-30End: 2018-12-27Updated: 2021-01-19